248 related articles for article (PubMed ID: 30133128)
21. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
Zhou J; Hui X; Mao Y; Fan L
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
[TBL] [Abstract][Full Text] [Related]
23. Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer.
Shan Z; Wang W; Tong Y; Zhang J
Med Sci Monit; 2021 Mar; 27():e929558. PubMed ID: 33758160
[TBL] [Abstract][Full Text] [Related]
24. Identification of Key Genes and Signaling Pathways Associated with the Progression of Gastric Cancer.
Yu C; Chen J; Ma J; Zang L; Dong F; Sun J; Zheng M
Pathol Oncol Res; 2020 Jul; 26(3):1903-1919. PubMed ID: 31848941
[TBL] [Abstract][Full Text] [Related]
25. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
Wang F; Chen C; Chen WP; Li ZL; Cheng H
Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
[TBL] [Abstract][Full Text] [Related]
26. Integrated Bioinformatics Analysis Identifies Hub Genes Associated with the Pathogenesis and Prognosis of Esophageal Squamous Cell Carcinoma.
Zhang H; Zhong J; Tu Y; Liu B; Chen Z; Luo Y; Tang Y; Xiao F; Zhong J
Biomed Res Int; 2019; 2019():2615921. PubMed ID: 31950035
[TBL] [Abstract][Full Text] [Related]
27. [Screening of differentially expressed genes in gastric cancer based on GEO database and function and pathway enrichment analysis].
Liang Y; Lai Y; Yuan Y; Yuan W; Zhang X; Zhang B; Lu Z
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):605-616. PubMed ID: 38597453
[TBL] [Abstract][Full Text] [Related]
28. Identification of Key Genes and Circular RNAs in Human Gastric Cancer.
Hao S; Lv J; Yang Q; Wang A; Li Z; Guo Y; Zhang G
Med Sci Monit; 2019 Apr; 25():2488-2504. PubMed ID: 30948703
[TBL] [Abstract][Full Text] [Related]
29. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
30. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing.
Zhao X; Wu S; Jing J
Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080
[No Abstract] [Full Text] [Related]
31. Bioinformatics Identification of Therapeutic Gene Targets for Gastric Cancer.
Li Y; Chen M; Chen Q; Yuan M; Zeng X; Zeng Y; He M; Wang B; Han B
Adv Ther; 2023 Apr; 40(4):1456-1473. PubMed ID: 36694099
[TBL] [Abstract][Full Text] [Related]
32. COL1A2 is a Novel Biomarker to Improve Clinical Prediction in Human Gastric Cancer: Integrating Bioinformatics and Meta-Analysis.
Rong L; Huang W; Tian S; Chi X; Zhao P; Liu F
Pathol Oncol Res; 2018 Jan; 24(1):129-134. PubMed ID: 28401451
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics analysis identifies biomarkers associated with poor prognosis in diffuse‑type gastric cancer.
Li S; Yu C; Cheng Y; Du F; Wen G
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495829
[TBL] [Abstract][Full Text] [Related]
34. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
Li T; Gao X; Han L; Yu J; Li H
World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
[TBL] [Abstract][Full Text] [Related]
35. Identification of hub genes correlated with the pathogenesis and prognosis of gastric cancer via bioinformatics methods.
Nie K; Shi L; Wen Y; Pan J; Li P; Zheng Z; Liu F
Minerva Med; 2020 Jun; 111(3):213-225. PubMed ID: 31638362
[TBL] [Abstract][Full Text] [Related]
36. Discovery of signature genes in gastric cancer associated with prognosis.
Zhao X; Cai H; Wang X; Ma L
Neoplasma; 2016; 63(2):239-45. PubMed ID: 26774142
[TBL] [Abstract][Full Text] [Related]
37. Identification of Transcriptional Markers and microRNA-mRNA Regulatory Networks in Colon Cancer by Integrative Analysis of mRNA and microRNA Expression Profiles in Colon Tumor Stroma.
Uddin MN; Li M; Wang X
Cells; 2019 Sep; 8(9):. PubMed ID: 31500382
[TBL] [Abstract][Full Text] [Related]
38. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
[TBL] [Abstract][Full Text] [Related]
40. Key Genes Associated with Prognosis and Tumor Infiltrating Immune Cells in Gastric Cancer Patients Identified by Cross-Database Analysis.
Zhang T; Wang BF; Wang XY; Xiang L; Zheng P; Li HY; Tao PX; Wang DF; Gu BH; Chen H
Cancer Biother Radiopharm; 2020 Nov; 35(9):696-710. PubMed ID: 32401038
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]